IPOs

With lung drug from Pfizer in hand, AN2 tests IPO waters in turbulent market
MedCity News
Tue, 03/8/22 - 10:01 am
AN2 Therapeutics
Okyo Pharma
IPOs
clinical trials
lung disease
dry eye disease
Financing roundup: Electra’s Star debut, Kallyope’s cash, Memo’s money & more
MedCity News
Tue, 02/22/22 - 10:48 am
biotech
IPOs
Electra Therapeutics
Kallyope
Memo Therapeutics
Centauri Therapeutics
SpliceBio
Third Harmonic Bio
Synthego
NMD Pharma
funding
Biotech IPOs in the current market environment? Experts say it's 'a bit silly, if not suicidal'
Fierce Biotech
Tue, 02/22/22 - 10:40 am
biotech
IPOs
pandemic
COVID-19
Arcellx’s IPO raises $124M to fuel chase of better CAR T-cell therapy for cancer
MedCity News
Tue, 02/8/22 - 09:53 am
Arcellx
IPOs
CAR-T
funding
cell therapy
Multiple Myeloma
No regrets as Lyell prepares for its first clinical trial
EP Vantage
Mon, 02/7/22 - 11:13 am
Lyell Immunopharma
IPOs
clinical trials
cell therapy
cancer
oncology
'The music stopped': Biotech rout leaves drug startups grounded as demand slumps for IPOs
BioPharma Dive
Mon, 02/7/22 - 10:08 am
biotech
startups
IPOs
funding
Arcellx raises $124M in Wall Street debut to bankroll study of multiple myeloma CAR-T
Fierce Biotech
Fri, 02/4/22 - 11:01 am
Arcellx
IPOs
Multiple Myeloma
Bausch + Lomb’s IPO plans come into focus as BHC prepares to split into three
MedCity News
Sun, 01/16/22 - 03:47 am
Bausch Health
IPOs
As three biotechs head to Wall Street, a battered sector braces for a pullback
BioPharma Dive
Fri, 01/7/22 - 10:34 am
Amylyx
CinCor
Vigil Neuroscience
IPOs
biotech
Gene therapy player Affinia aims to go public, hoping to raise big money in effort to remake AAVs
Endpoints
Wed, 01/5/22 - 10:37 am
Affinia Therapeutics
IPOs
gene therapy
funding
Cell therapy, AI drug discovery highlight 2021’s record year in biotech IPOs
MedCity News
Fri, 12/31/21 - 11:04 am
IPOs
cell therapy
artificial intelligence
Sana Biotechnology
Lyell Immunopharma
Caribou Biosciences
Instil Bio
Talaris Therapeutics
Achilles Therapeutics
Italian cancer gene therapy biotech makes history with modest Nasdaq IPO
Endpoints
Thu, 12/16/21 - 11:08 am
gene therapy
IPOs
NASDAQ
Genenta
Italy
Biotech Companies Launch or Plan IPOs: Vaxxinity, Genenta and Enetrada
BioSpace
Thu, 11/11/21 - 11:26 pm
IPOs
Vaxxinity
Genenta Science
Enetrada
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Fierce Biotech
Thu, 11/11/21 - 11:03 am
Vaxxinity
IPOs
vaccines
immunotherapy
NASDAQ
Gyroscope spins the wheel again as it taps Sanofi for $60M months after ditching IPO attempt
Fierce Biotech
Mon, 11/8/21 - 10:51 am
IPOs
Gyroscope Therapeutics
Sanofi
First Day Trading a Letdown for LianBio in Shadow of Beijing Market Crackdown
BioSpace
Tue, 11/2/21 - 11:42 pm
LianBio
Beijing
IPOs
NASDAQ
Ventyx nabs a $152M upsized IPO to challenge BMS' Zeposia—and a backer with intimate knowledge of its rival
Fierce Biotech
Fri, 10/22/21 - 12:04 pm
Ventyx Biosciences
IPOs
autoimmune disease
Bristol Myers Squibb
Zeposia
Xilio Therapeutics goes public as biopharma IPOs rumble forward in Q4
Endpoints
Fri, 10/22/21 - 12:02 pm
Xilio Therapeutics
IPOs
solid tumors
Two Biopharmas Nix IPO Plans in Unstable Market
BioSpace
Thu, 10/21/21 - 11:18 pm
NASDAQ
IPOs
AEON Biopharma
Cingulate
IPO floodgates open up after summer lull as five more biotechs file for Nasdaq
Endpoints
Tue, 10/12/21 - 10:59 am
Evotec
Entrada Therapeutics
Aura Biosciences
Vaxxinity
Blue Water Vaccines
IPOs

Pages